Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The normal human prostate does not significantly affect blood DHT levels.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Animal models are crucial for learning about hair loss and finding treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Non-obese women with hair loss have higher heart disease risk.

Combination therapies work better than single treatments for hair loss.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Hair transplantation for men has improved, offering natural, lasting results, and may be enhanced by certain medications and future technologies.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.